List prices and clinical value of anticancer drugs in China, Japan, and South Korea: a retrospective comparative studyResearch in context

• Main Authors: Jay Pan (Author), Xiaolin Wei (Author), Hao Lu (Author), Xueer Wu (Author), Chunyuan Li (Author), Xuelian Hai (Author), Tianjiao Lan (Author), Quanfang Dong (Author), Yili Yang (Author), Mihajlo Jakovljevic (Author), Jing Zhou (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: High prices of anticancer drugs have raised concerns due to their financial impact on patients and healthcare systems. This study aimed to assess the initial and latest list prices and clinical value of reimbursed anticancer drugs in China, Japan, and South Korea. Methods: We id...